Cargando…
Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
High mobility group box 1 (HMGB1) is a nuclear protein that can interact with a receptor for advanced glycation end-products (RAGE; a multi-ligand immunoglobulin receptor) and mediates the inflammatory pathways that lead to various pathological conditions, such as cancer, diabetes, neurodegenerative...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658169/ https://www.ncbi.nlm.nih.gov/pubmed/36364135 http://dx.doi.org/10.3390/molecules27217311 |